Hexagon Capital Partners LLC Takeda Pharmaceutical CO LTD Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 4,419 shares of TAK stock, worth $59,170. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,419
Previous 3,290
34.32%
Holding current value
$59,170
Previous $42,000
47.62%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding TAK
# of Institutions
330Shares Held
73.6MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$176 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$71.7 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$68.2 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$62.1 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$61.1 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.6B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...